Marinus Pharmaceuticals (MRNS) Short Interest Ratio & Short Volume → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free MRNS Stock Alerts $1.33 -0.05 (-3.62%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Marinus Pharmaceuticals Short Interest DataCurrent Short Volume5,000,000 sharesPrevious Short Volume4,520,000 sharesChange Vs. Previous Month+10.62%Dollar Volume Sold Short$7.05 millionShort Interest Ratio / Days to Cover2.7Last Record DateApril 30, 2024Outstanding Shares54,930,000 sharesPercentage of Shares Shorted9.10%Today's Trading Volume2,058,410 sharesAverage Trading Volume5,009,998 sharesToday's Volume Vs. Average41% Short Selling Marinus Pharmaceuticals ? Sign up to receive the latest short interest report for Marinus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMRNS Short Interest Over TimeMRNS Days to Cover Over TimeMRNS Percentage of Float Shorted Over Time Ad Colonial MetalsCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public. Marinus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20245,000,000 shares $7.05 million +10.6%N/A2.7 $1.41 4/15/20244,520,000 shares $5.88 million +30.3%N/A2.7 $1.30 3/31/20243,470,000 shares $31.37 million -2.8%N/A7.7 $9.04 3/15/20243,570,000 shares $33.52 million +4.1%N/A8.2 $9.39 2/29/20243,430,000 shares $32.59 million -3.9%N/A7.9 $9.50 2/15/20243,570,000 shares $35.70 million -1.4%N/A9.1 $10.00 Get the Latest News and Ratings for MRNS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Marinus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,620,000 shares $35.26 million -6.0%N/A8.8 $9.74 1/15/20243,850,000 shares $37.73 million -12.3%N/A8.8 $9.80 12/31/20234,390,000 shares $47.72 million +12.0%N/A10.1 $10.87 12/15/20233,920,000 shares $33.67 million -1.0%N/A8.7 $8.59 11/30/20233,960,000 shares $26.65 million -13.0%N/A8 $6.73 11/15/20234,550,000 shares $28.03 million +2.7%N/A8.1 $6.16 10/31/20234,430,000 shares $30.74 million +15.1%N/A6.6 $6.94 10/15/20233,850,000 shares $26.49 million +6.1%N/A5.8 $6.88 9/30/20233,630,000 shares $29.22 million -4.2%N/A5.4 $8.05 9/15/20233,790,000 shares $23.12 million +5.6%N/A5.3 $6.10 8/31/20233,590,000 shares $25.52 million +7.5%N/A4.3 $7.11 8/15/20233,340,000 shares $20.47 million +14.0%N/A4 $6.13 7/31/20232,930,000 shares $31.18 million -9.3%N/A3.5 $10.64 7/15/20233,230,000 shares $31.85 million +17.0%N/A3.7 $9.86 6/30/20232,760,000 shares $29.97 million +54.2%N/A3 $10.86 6/15/20231,790,000 shares $17.54 million +17.0%N/A2.1 $9.80 5/31/20231,530,000 shares $10.88 million -16.4%N/A2.2 $7.11 5/15/20231,830,000 shares $15.77 million +19.6%N/A2.9 $8.62 4/30/20231,530,000 shares $13.92 million -19.9%N/A2.7 $9.10 4/15/20231,910,000 shares $14.11 million +7.3%N/A3.8 $7.39 3/31/20231,780,000 shares $12.28 million +17.1%N/A3.8 $6.90 3/15/20231,520,000 shares $10.06 million +7.0%N/A3.5 $6.62 2/28/20231,420,000 shares $9.80 million +6.8%N/A3.6 $6.90 2/15/20231,330,000 shares $9.02 million +2.3%N/A3.6 $6.78 1/31/20231,300,000 shares $8.26 million -7.8%N/A3.1 $6.35 1/15/20231,410,000 shares $6.97 million +3.7%N/A3.8 $4.94 12/30/20221,360,000 shares $5.41 million +5.4%N/A4.2 $3.98 12/15/20221,290,000 shares $5.29 million +1.6%N/A4 $4.10 11/30/20221,270,000 shares $6.08 million -1.6%N/A4 $4.79 11/15/20221,290,000 shares $6.18 million -12.2%N/A4.6 $4.79 10/31/20221,470,000 shares $8.45 million +6.5%4.5%5.5 $5.75 10/15/20221,380,000 shares $7.40 million -5.5%4.3%6.3 $5.36 9/30/20221,460,000 shares $9.71 million +29.2%4.5%7 $6.65 9/15/20221,130,000 shares $7.55 million +3.7%3.5%4 $6.68The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide MRNS Short Interest - Frequently Asked Questions What is Marinus Pharmaceuticals' current short interest? Short interest is the volume of Marinus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 5,000,000 shares of MRNS short. Learn More on Marinus Pharmaceuticals' current short interest. What is a good short interest ratio for Marinus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRNS shares currently have a short interest ratio of 3.0. Learn More on Marinus Pharmaceuticals's short interest ratio. Is Marinus Pharmaceuticals' short interest increasing or decreasing? Marinus Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 5,000,000 shares, an increase of 10.6% from the previous total of 4,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Marinus Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Marinus Pharmaceuticals: BioXcel Therapeutics, Inc. (4.05%), Barinthus Biotherapeutics plc (0.05%), Connect Biopharma Holdings Limited (0.06%), Chimerix, Inc. (1.71%), Spero Therapeutics, Inc. (0.87%), Oncolytics Biotech Inc. (1.14%), Corvus Pharmaceuticals, Inc. (3.69%), Jaguar Health, Inc. (5.19%), Hookipa Pharma Inc (0.91%), ProPhase Labs, Inc. (1.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Marinus Pharmaceuticals stock? Short selling MRNS is an investing strategy that aims to generate trading profit from Marinus Pharmaceuticals as its price is falling. MRNS shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Marinus Pharmaceuticals? A short squeeze for Marinus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRNS, which in turn drives the price of the stock up even further. How often is Marinus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRNS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: BTAI Short Interest BRNS Short Interest CNTB Short Interest CMRX Short Interest SPRO Short Interest ONCY Short Interest CRVS Short Interest JAGX Short Interest HOOK Short Interest PRPH Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRNS) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsObama’s Forever Term [exposed]Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press